Public health effectiveness of the FDA 510(k) clearance process : balancing patient safety and innovation : workshop report / Theresa Wizemann, editor ; Committee on the Public Health Effectiveness of the FDA 510(k) clearance process, Board on Population Health and Public Health Practice, Institute of Medicine of the National Academies.
| Other author/creator | Wizemann, Theresa M. |
| Other author/creator | Institute of Medicine (U.S.). Board on Population Health and Public Health Practice. |
| Other author/creator | Institute of Medicine (U.S.). Committee on the Public Health Effectiveness of the FDA 510(k) Clearance Process. |
| Format | Electronic and Book |
| Publication Info | Washington, D.C. : National Academies Press, [2010] |
| Description | xii, 128 pages : illustrations (some color) ; 23 cm |
| Supplemental Content | Full text available from Ebook Central - Academic Complete |
| Subject(s) |
Click here for more information about this title
| Portion of title | FDA 510(k) clearance process |
| Abstract | "The Food and Drug Administration (FDA) is responsible for assuring that medical devices are safe and effective before they go on the market. As part of its assessment of FDA's premarket clearance process for medical devices, the IOM held a workshop June 14-15 to discuss how to best balance patient safety and technological innovation. This document summarizes the workshop."-- Source other than Library of Congress. |
| Bibliography note | Includes bibliographical references. |
| Access restriction | Available only to authorized users. |
| Technical details | Mode of access: World Wide Web |
| Genre/form | Electronic books. |
| LCCN | 2012405517 |
| ISBN | 9780309158497 (pbk.) |
| ISBN | 0309158494 (pbk.) |
Available Items
| Library | Location | Call Number | Status | Item Actions | |
| Electronic Resources | Access Content Online | ✔ Available |